Digitoxin FDA Link

A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)

Also Known As:

Coramedan; Digimed; Digimerck; Digitaline Nativelle; Digitoxin AWD; Digitoxin Bürger; Digitoxin Didier; Digitoxin-Philo; Digophton; AWD, Digitoxin; Bürger, Digitoxin; Didier, Digitoxin; Digitoxin Philo; Nativelle, Digitaline; Card-20(22)-enolide, 3- ((O- 2,6- dideoxy- beta- D- ribo- hexopyranosyl- (1- 4)- O- 2,6- dideoxy- beta- D- ribo- hexopyranosyl- (1- 4)- 2,6- dideoxy- beta- D- ribo- hexopyranosyl)oxy)- 14- hydroxy- , (3beta,5beta)-

Pharmalogical Action Categories:

Anti-Arrhythmia Agents
Cardiotonic Agents
Enzyme Inhibitors

Polycyclic Compounds: 7
- Fused-Ring Compounds
  - Steroids: 71426
    - Cardanolides
      - Cardiac Glycosides: 1017
        Cardenolides: 139
        Digitoxin: 366
        Digitalis Glycosides: 147
        Digitoxin: 366
Carbohydrates: 22516
- Glycosides: 2186
  - Cardiac Glycosides: 1017
    - Digitalis Glycosides: 147
      - Digitoxin: 366

Y Loubières Selected Research

Y Loubières Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure